Articles

  • 6 days ago | insights.citeline.com | Shubham Singh

    J&J Survey: Clinician Burnout And Aging Populations Drive Demand For AI And Robotics In Future Health CareA Global Pulse Check Finds Optimism In AI, Robotics And Data-Driven Solutions For Aging Care. According to a survey of health care professionals by J&J, over 45% of surveyed respondents reported experiencing symptoms of burnout, including emotional exhaustion and reduced sense of personal accomplishment. This affects not just clinicians, but also the quality and safety of care they deliver.

  • 1 week ago | insights.citeline.com | Shubham Singh

    Indian Medtechs Call US Tariffs A Challenge To Growth And Seek Reciprocal Regulatory AccessIndian Medtech Firms Urge US To Level The Playing Field With Fair Tariffs And Reciprocal Regulatory AccessIndia’s medical technology industry is raising the alarm over steep new US tariffs on imported medical devices. It argues for structural change to address “unequal regulatory access” and non-tariff barriers.

  • 1 week ago | insights.citeline.com | Shubham Singh

    J&J Medtech’s FDA-Cleared DUALTO System Prepares For Future Use With OTTAVA Robotic PlatformFuture-Ready Surgical Energy Platform Designed For Flexibility, Precision And Robotic IntegrationDUALTO’s double-module option provides enhanced flexibility while cutting down on equipment clutter. Compared to traditional setups, the system reduces OR footprint by 46%, helping staff reclaim space and optimize surgical workflows.

  • 1 week ago | insights.citeline.com | Shubham Singh

    OneCell Diagnostics’ Mohan Uttarwar Discusses Liquid Biopsy Breakthroughs And The Future Of Precision OncologyFirm Co-Founder Outlines How Science Meets Scale In Second Part Of The InterviewOneCell’s co-founder Uttarwar discusses clinical validation milestones, CLIA certification, and the startup’s strategic roadmap – from hospital partnerships in India to biopharma collaborations in the US.

  • 1 week ago | insights.citeline.com | Shubham Singh

    Dexcom Promotes CGM As First-Line Tool In Type 2 DiabetesCompany Combines Education, Advocacy And Clinical Studies To Shift Standard Of Treatment. Only 14% of people with type 2 diabetes use continuous glucose monitors, although 93% of users report a positive impact on their health. Dexcom is ramping up efforts to close this adoption gap.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
487
Tweets
497
DMs Open
No
Shubham Singh
Shubham Singh @shubhamsingh915
13 Feb 24

Cocktails, hookah, and a hefty bill: A Delhi man's day out with a Tinder swindler and how you can avoid it - BusinessToday https://t.co/16ZzFdlUuz

Shubham Singh
Shubham Singh @shubhamsingh915
23 Dec 23

Eight months after Bournvita row, Cadbury slashes added sugar by nearly 15%; 'Food Pharmer' says 'India wins' https://t.co/UBqBbYv1pn

Shubham Singh
Shubham Singh @shubhamsingh915
9 Oct 23

'Goodbye to my wife India': Israeli journalist bids farewell to serve in military amid war with Hamas... via @business_today https://t.co/t2S1gkkzg7